Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent active pharmaceutical ingredients (APIs) enter the processing pipeline, such as cytotoxic drugs to treat cancer.
Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and cataylysts filtered from the APIs. To help remedy the problem, Pall is introducing the GBK Containment System which provides the pharmaceutical industry with an all-in-one contained glove bag/housing system for filter change-out.
Bioss In Vivo Biosimilar Antibodies
Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...
LSBio virology research products
LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...
Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates
The products provide research flow cytometry labs with a low-noise solution, including single...
